1hy7: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:1hy7.jpg|left|200px]] | [[Image:1hy7.jpg|left|200px]] | ||
<!-- | |||
The line below this paragraph, containing "STRUCTURE_1hy7", creates the "Structure Box" on the page. | |||
You may change the PDB parameter (which sets the PDB file loaded into the applet) | |||
or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |||
or leave the SCENE parameter empty for the default display. | |||
--> | |||
{{STRUCTURE_1hy7| PDB=1hy7 | SCENE= }} | |||
}} | |||
'''A CARBOXYLIC ACID BASED INHIBITOR IN COMPLEX WITH MMP3''' | '''A CARBOXYLIC ACID BASED INHIBITOR IN COMPLEX WITH MMP3''' | ||
| Line 47: | Line 44: | ||
[[Category: Pikul, S.]] | [[Category: Pikul, S.]] | ||
[[Category: Pokross, M E.]] | [[Category: Pokross, M E.]] | ||
[[Category: | [[Category: Inhibited]] | ||
[[Category: | [[Category: Mixed alpha beta structure]] | ||
[[Category: | [[Category: Zinc protease]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 19:21:09 2008'' | |||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | |||
Revision as of 19:21, 2 May 2008
A CARBOXYLIC ACID BASED INHIBITOR IN COMPLEX WITH MMP3
OverviewOverview
A series of carboxylic acids were prepared from a propargylglycine scaffold and tested for efficacy as matrix metalloproteinase (MMP) inhibitors. Detailed SAR for the series is reported for four enzymes within the MMP family. The inhibitors were typically potent against collagenase-3 (MMP-13) and gelatinase A (MMP-2), while they spared collagenase-1 (MMP-1) and only moderately inhibited stromelysin (MMP-3). Compound 40 represents a typical inhibition profile of a compound with reasonable potency. Introduction of polar groups was required in order to generate inhibitors with acceptable water solubility, and this often resulted in a loss of potency as in compound 63. High serum protein binding proved to be a difficult hurdle with many compounds such as 48 showing >99% binding. Some compounds such as 64 displayed approximately 90% binding, but no reliable method was discovered for designing molecules with low protein binding. Finally, selected data regarding the pharmacokinetic behavior of these compounds is presented.
DiseaseDisease
Known disease associated with this structure: Coronary heart disease, susceptibility to OMIM:[185250]
About this StructureAbout this Structure
1HY7 is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
ReferenceReference
Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines., Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE, J Med Chem. 2001 Mar 29;44(7):1060-71. PMID:11297453 Page seeded by OCA on Fri May 2 19:21:09 2008
Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)
OCA- Pages with broken file links
- Homo sapiens
- Single protein
- Stromelysin 1
- Almstead, N G.
- Baker, T R.
- Bookland, R G.
- Branch, T M.
- De, B.
- Foltz, D J.
- Garver, S M.
- Gu, F.
- Hsieh, L C.
- Janusz, M J.
- King, S L.
- Laufersweiler, M J.
- Mieling, G E.
- Natchus, M G.
- Patel, V S.
- Peng, S X.
- Pikul, S.
- Pokross, M E.
- Inhibited
- Mixed alpha beta structure
- Zinc protease